Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

PDF) Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling

PDF) Vectorial Competence of Larvae and Adults of Alphitobius diaperinus in the Transmission of Salmonella Enteritidis in Poultry

New Trends in Vaccine Development

Vetanco Vetanco's presence at the Latin American Scientific Conference

Frontiers Differential Effects of Bacitracin Methylene Disalicylate (BMD) on the Distal Colon and Cecal Microbiota of Young Broiler Chickens

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

PDF) Evaluation of a subunit vaccine candidate (Biotech Vac Cox) against Eimeria spp. in broiler chickens

Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept

Diretora de Biotecnologia da Vetanco/BV Science no European Animal Microbiome Congress – O Presente Rural

Vetanco Biotech Vac will participate in a special episode of the TV series Advancements

Frontiers Development of the Tonsil Microbiome in Pigs and Effects of Stress on the Microbiome

Frontiers Differential Effects of Bacitracin Methylene Disalicylate (BMD) on the Distal Colon and Cecal Microbiota of Young Broiler Chickens

Sherry Layton - Chief Executive Officer - Vetanco USA

Vaccines Conference-2022, Global Conference on Vaccines Research and Development